We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$511M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
224
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17% |
| 2 | Technology | 14.79% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boston Scientific
BSX
$68.4B
| $91.1M | 0.22% |
2,239,746
+668
| +0% | +$28.3K |
|
102
West Pharmaceutical
WST
$23.5B
| $89.5M | 0.22% |
631,069
-162,186
| -20% | -$22.3M |
|
103
Tandem Diabetes Care
TNDM
$1.23B
| $89.3M | 0.22% |
1,514,333
-26,482
| -2% | -$1.69M |
|
104
DexCom
DXCM
$29B
| $89.2M | 0.22% |
2,389,568
+26,520
| +1% | +$1.03M |
|
105
Baxter International
BAX
$12.8B
| $88.1M | 0.22% |
1,006,780
-30,459
| -3% | -$2.6M |
|
106
Repligen
RGEN
$7.09B
| $87.5M | 0.21% |
1,140,323
+146,354
| +15% | +$12.8M |
|
107
Insulet
PODD
$11.8B
| $86M | 0.21% |
521,587
-7,613
| -1% | -$1.07M |
|
|
AL
108
DELISTED
Air Lease Corp
AL
| $84.8M | 0.21% |
2,028,400
-128,500
| -6% | -$5.29M |
|
109
TC Energy
TRP
$70.7B
| $84.5M | 0.21% |
1,630,976
+1,377,371
| +543% | +$68.8M |
|
110
Enbridge
ENB
$121B
| $83.7M | 0.21% |
2,384,888
+431,500
| +22% | +$14.9M |
|
111
American Tower
AMT
$81.7B
| $82.6M | 0.2% |
373,544
-33,287
| -8% | -$7.26M |
|
112
Accenture
ACN
$105B
| $82.1M | 0.2% |
426,979
-49,644
| -10% | -$9.61M |
|
113
Las Vegas Sands
LVS
$32B
| $82M | 0.2% |
1,418,831
+36,996
| +3% | +$2.16M |
|
114
Prudential Financial
PRU
$43B
| $81.9M | 0.2% |
911,002
-42,820
| -4% | -$3.88M |
|
115
Reinsurance Group of America
RGA
$15.7B
| $81.2M | 0.2% |
508,191
-29,832
| -6% | -$4.62M |
|
116
Berkshire Hathaway Class B
BRK.B
$1.1T
| $80.4M | 0.2% |
386,441
-57,539
| -13% | -$11.9M |
|
117
L3Harris
LHX
$55.6B
| $79.8M | 0.2% |
382,611
+353,918
| +1,233% | +$72.5M |
|
|
HES
118
DELISTED
Hess
HES
| $79.7M | 0.2% |
1,318,327
-89,065
| -6% | -$5.55M |
|
119
Vulcan Materials
VMC
$37.6B
| $79.5M | 0.2% |
525,628
+192,387
| +58% | +$27.2M |
|
|
JBGS
120
JBG SMITH
JBGS
$858M
| $77.5M | 0.19% |
1,976,063
-79,821
| -4% | -$3.11M |
|
121
Hamilton Lane
HLNE
$3.85B
| $77.4M | 0.19% |
1,359,200
| – | – |
|
122
Ryman Hospitality Properties
RHP
$8.58B
| $77.4M | 0.19% |
945,800
+83,125
| +10% | +$6.58M |
|
123
Eagle Materials
EXP
$6.7B
| $77.2M | 0.19% |
857,972
-119,282
| -12% | -$10.2M |
|
124
CALL
iShares Russell 2000 ETF
IWM
$79.4B
| $76.2M | 0.19% |
50,000
| – | – |
|
125
CBRE Group
CBRE
$44.1B
| $75M | 0.18% |
1,414,918
+92,308
| +7% | +$4.85M |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 224 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 224 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.